Paul Cockle

Paul has over 25 years of experience in vaccine research, in both the prophylactic and therapeutic setting. He has worked in the pharmaceutical industry and the biotechnology sector in the US and the UK. Recently, his focus has been in the field of oncology, with positions at Silverback Therapeutics, PsiOxus Therapeutics, and Gritstone Bio. Prior to this Paul was at Pfizer for 9 years, where he was head of Immunology within the Vaccine Research group and a Research Project Leader for the VBIR cancer vaccine program. At Pfizer he led the immunology team in the research of vaccines for infectious disease and therapeutic targets.

Paul holds a PhD in Clinical Medicine from the University of Oxford (UK) and performed his postdoctoral training at the Animal and Plant Health Agency (UK) developing a vaccine against tuberculosis.